auto_awesome
Tracking this entity every week?
Watch this entity, get an email digest the moment they win, lose, or are recompete-eligible. Free on every plan.
Capture intelligence
Competitive signals derived from disclosed federal contract history.
- Sole-source share
- 80%
- of disclosed contracts awarded non-competitively
- Amendment growth
- 1.00×
- final contract value vs original award
- Recompete exposure
- 0
- contracts ending within 24 months
- Buyer footprint
- 1
- federal departments with disclosed contracts
Dr. Peter Jamieson
SaveTotal Contracts
5
Total Value
$102.7K
Departments
1
Years Active
5
2020-2021 to 2024-2025
Top Departments
| Department | Contracts | Total Value |
|---|---|---|
| Patented Medicine Prices Review Board Canada | 5 | $102.7K |
Solicitation Breakdown
Competitive: 20% (1)
Non-competitive: 80% (4)
Recent Contracts
Page 1 of 1 · 36 total contracts
| Department | Value | Date | Description |
|---|---|---|---|
| Patented Medicine Prices Review Board Canada | $20.0K | 2024-04-01 | Scientific consultants |
| Patented Medicine Prices Review Board Canada | $26.0K | 2023-04-05 | Scientific consultants |
| Patented Medicine Prices Review Board Canada | $22.0K | 2022-04-19 | Scientific consultants |
| Patented Medicine Prices Review Board Canada | $17.0K | 2021-04-01 | Scientific consultants |
| Patented Medicine Prices Review Board Canada | $17.7K | 2020-04-01 | Scientific consultants |
See Dr. Peter Jamieson's award history →
View standing offers, supply arrangements, and award notices for this vendor.
Explore More Government Data
IT Spending by Department
Federal technology budgets and consulting spend trends
Departmental Budgets
Budget breakdowns for every federal department and agency
Grants & Contributions
Federal grants from ISED, NRC, and regional development agencies
Contract Awards
Track who wins government contracts and award patterns
Standing Offers
Browse TBIPS, ProServices, and other procurement vehicles
Buy Canadian Policy
Guide to the 2025-2026 domestic procurement policy
Indigenous Procurement
PSAB, mandatory set-asides, and the 5% target